Results 1 to 10 of about 108,822 (154)
Medical Clinics of North America, 1998 Nonproliferative diabetic retinopathy may cause visual loss when associated with macular edema or macular ischemia (secondary to retinal capillary nonperfusion). Proliferative diabetic retinopathy may cause severe visual loss if complicated by vitreous hemorrhage or traction detachment of the macula.
K A, Neely +4 more
+7 more sources
IJRETINA (International Journal of Retina), 2021 Introduction Apolipoprotein A1 are antiatherogenic in blood serum and have an anti-inflammatory while Apolipoprotein B describes a protein structure that is potentially atherogenic..
shabrina hanifah +4 more
doaj +1 more source
Journal of Diabetes Research, 2021 Aims/Introduction. To investigate whether the occurrence of early worsening of diabetic retinopathy in patients with type 2 diabetes diagnosed with simple or preproliferative diabetic retinopathy at their first visit differed according to HbA1c reduction
Sayaka Wakabayashi Sugawa +6 more
doaj +1 more source
Nature Reviews Disease Primers, 2016 Diabetic retinopathy (DR) is a common complication of diabetes mellitus and is a major cause of vision loss in middle-aged and elderly people. One-third of people with diabetes have DR. Severe stages of DR include proliferative DR, caused by the abnormal growth of new retinal blood vessels, and diabetic macular oedema, in which there is exudation and ...
Wong, Tien Y +4 more
openaire +5 more sources
BMJ Open Diabetes Research & Care, 2020 Introduction To evaluate the effects of intravitreal aflibercept injection on retinal nonperfusion in patients with diabetic retinopathy (DR) using ultrawide field (UWF) fluorescein angiography (FA).Research design and methods Thirty-eight eyes of 38 ...
Young Hee Yoon +2 more
doaj +1 more source
Home Health Care Intervention for Diabetic Retinopathy Patients and their Caregivers to Improve Patients` Quality of Life [PDF]
Egyptian Journal of Health Care, 2017 The aim of this study was to evaluate home health care intervention for diabetic retinopathy patients and their caregivers to improve patients` quality of life. Design: A quasi- experimental design was utilized.
Hanaa Abd El-Gawad Abd El-Megeed +2 more
doaj +1 more source
Journal of Medical Screening, 1996 Diabetic retinopathy is a leading cause of loss of vision in the United States. Results of recent population-based studies and randomized controlled clinical trials suggest that glycemic control can lower the incidence and prevent the progression of retinopathy and loss of vision associated with diabetes.
A D, Penman, M M, Engelgau
+9 more sources
Nihon Naika Gakkai Zasshi, 2000 Introduction: To provide a review of the current standard of care in diabetic eye management. Methods: A non-systematic evidence-based review utilising available data and consensus statements on the subject matter. Results: Diabetes mellitus affects some 9.0% of Singaporeans, and more than 60% of patients with diabetes in this population remained ...
I, Oonuma, H, Yamashita
openaire +5 more sources
Clinical Cornerstone, 2003 Diabetic retinopathy is the principal cause of irreversible blindness in patients of working age in the industrialized world (1,2). For some types of retinopathy (e.g., proliferative disease), effective treatment in the form of laser photocoagulation has been available for more than 20 years, but many patients seek help too late when treatment is no ...
Susan, Lightman, Hamish M, Towler
openaire +5 more sources
Postgraduate Medical Journal, 1984 Involvement of the retinal microvascular vessels is an almost inevitable consequence of long standing diabetes. In the only large scale epidemiology study of a Caucasian population Klein et al. found some degree of retinopathy in up to 97% of patients with insulin dependent diabetes mellitus (IDDM) after about 15 years diabetes duration and in about 60%
openaire +6 more sources